B3GALNT1 and lung carcinoma: The GALT3 peptides may also be applicable for other cancers, since peptide-specific CTLs could be induced in PBMCs of a lung cancer patient (Figure 6A) and the GALT3 expression was observed in various tumour cell lines (data not shown).